CA2403909A1 - Compositions and methods for the therapy and diagnosis of prostate cancer - Google Patents
Compositions and methods for the therapy and diagnosis of prostate cancer Download PDFInfo
- Publication number
- CA2403909A1 CA2403909A1 CA002403909A CA2403909A CA2403909A1 CA 2403909 A1 CA2403909 A1 CA 2403909A1 CA 002403909 A CA002403909 A CA 002403909A CA 2403909 A CA2403909 A CA 2403909A CA 2403909 A1 CA2403909 A1 CA 2403909A1
- Authority
- CA
- Canada
- Prior art keywords
- seq
- sequence
- cdna sequence
- polypeptide
- sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (23)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US53685700A | 2000-03-27 | 2000-03-27 | |
US09/536,857 | 2000-03-27 | ||
US56810000A | 2000-05-09 | 2000-05-09 | |
US09/568,100 | 2000-05-09 | ||
US09/570,737 | 2000-05-12 | ||
US09/570,737 US7202342B1 (en) | 1999-11-12 | 2000-05-12 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/593,793 | 2000-06-13 | ||
US09/593,793 US7517952B1 (en) | 1997-02-25 | 2000-06-13 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US60578300A | 2000-06-27 | 2000-06-27 | |
US09/605,783 | 2000-06-27 | ||
US09/636,215 US6620922B1 (en) | 1997-02-25 | 2000-08-09 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/636,215 | 2000-08-10 | ||
US09/651,236 | 2000-08-29 | ||
US09/651,236 US6818751B1 (en) | 1997-08-01 | 2000-08-29 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/657,279 US6894146B1 (en) | 1997-02-25 | 2000-09-06 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/657,279 | 2000-09-06 | ||
US09/679,426 US6759515B1 (en) | 1997-02-25 | 2000-10-02 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US09/679,426 | 2000-10-02 | ||
US09/685,166 | 2000-10-10 | ||
US09/685,166 US6630305B1 (en) | 1999-11-12 | 2000-10-10 | Compositions and methods for the therapy and diagnosis of prostate cancer |
US70972900A | 2000-11-09 | 2000-11-09 | |
US09/709,729 | 2000-11-09 | ||
PCT/US2001/009919 WO2001073032A2 (en) | 2000-03-27 | 2001-03-27 | Compositions and methods for the therapy and diagnosis of prostate cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2403909A1 true CA2403909A1 (en) | 2001-10-04 |
Family
ID=27582800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002403909A Abandoned CA2403909A1 (en) | 2000-03-27 | 2001-03-27 | Compositions and methods for the therapy and diagnosis of prostate cancer |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1311673A2 (enrdf_load_stackoverflow) |
JP (1) | JP2004504808A (enrdf_load_stackoverflow) |
AU (1) | AU2001249549A1 (enrdf_load_stackoverflow) |
CA (1) | CA2403909A1 (enrdf_load_stackoverflow) |
WO (1) | WO2001073032A2 (enrdf_load_stackoverflow) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030185830A1 (en) * | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
US7517952B1 (en) | 1997-02-25 | 2009-04-14 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
DE69840669D1 (de) | 1997-04-10 | 2009-04-30 | Stichting Katholieke Univ | Pca3, pca3-gene und verfahren zu ihrer verwendung |
US7037667B1 (en) | 1998-06-01 | 2006-05-02 | Agensys, Inc. | Tumor antigen useful in diagnosis and therapy of prostate and colon cancer |
US20030149531A1 (en) | 2000-12-06 | 2003-08-07 | Hubert Rene S. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
PT1086223E (pt) | 1998-06-01 | 2009-11-03 | Agensys Inc | Novos antigénios transmembranares em serpentina expressos em cancros humanos e suas utilizações |
US6833438B1 (en) | 1999-06-01 | 2004-12-21 | Agensys, Inc. | Serpentine transmembrane antigens expressed in human cancers and uses thereof |
US7083796B2 (en) | 2000-06-20 | 2006-08-01 | Corixa Corporation | Fusion proteins of mycobacterium tuberculosis |
US6943235B1 (en) | 1999-04-12 | 2005-09-13 | Agensys, Inc. | Transmembrane protein expressed in prostate cancer |
JP2003510075A (ja) | 1999-09-29 | 2003-03-18 | ディグノキュアー・インコーポレーテッド | 良性および悪性の前立腺組織におけるpca3メッセンジャーrna種 |
US7361338B2 (en) | 1999-10-05 | 2008-04-22 | Agensys, Inc. | Methods to inhibit growth of prostate cancer cells |
US7208280B2 (en) | 1999-10-05 | 2007-04-24 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 101P3A41 useful in treatment and detection of cancer |
US6790631B1 (en) | 1999-10-05 | 2004-09-14 | Agensys, Inc. | G protein-coupled receptor up-regulated in prostate cancer and uses thereof |
ES2282142T3 (es) * | 1999-10-07 | 2007-10-16 | Corixa Corporation | Una secuencia de micobacterium tuberculosis para la expresion de proteinas heterologas. |
US7776523B2 (en) | 2000-12-07 | 2010-08-17 | Novartis Vaccines And Diagnostics, Inc. | Endogenous retroviruses up-regulated in prostate cancer |
WO2002083921A2 (en) | 2001-04-10 | 2002-10-24 | Agensys, Inc. | Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
JP2005504513A (ja) * | 2001-05-09 | 2005-02-17 | コリクサ コーポレイション | 前立腺癌の治療及び診断のための組成物及び方法 |
CA2447564A1 (en) * | 2001-05-15 | 2002-11-21 | Agensys, Inc. | Nucleic acids and corresponding proteins entitled 101p3a11 or phor-1 useful in treatment and detection of cancer |
US6897024B2 (en) | 2001-05-31 | 2005-05-24 | Stichting Katholieke Universiteit More Particularly The University Medical Centre Nijmegen | Nucleic acid molecules comprising the promoter for PCA3, and uses thereof |
US7229774B2 (en) | 2001-08-02 | 2007-06-12 | Regents Of The University Of Michigan | Expression profile of prostate cancer |
US7332290B2 (en) | 2001-08-02 | 2008-02-19 | The Regents Of The University Of Michigan | Dectection of AMACR cancer markers in urine |
US7700293B2 (en) | 2001-08-02 | 2010-04-20 | The Regents Of The University Of Michigan | Expression profile of prostate cancer |
US7494646B2 (en) | 2001-09-06 | 2009-02-24 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
AU2002336446B2 (en) | 2001-09-06 | 2008-03-06 | Agensys, Inc. | Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
AU2003210663A1 (en) | 2002-01-25 | 2003-09-02 | The Regents Of The University Of California | Methods of modulating cold sensory perception |
MXPA04012443A (es) * | 2002-06-11 | 2005-04-19 | Glaxosmithkline Biolog Sa | Composiciones inmunogenicas. |
US20040081653A1 (en) | 2002-08-16 | 2004-04-29 | Raitano Arthur B. | Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer |
WO2004070056A2 (en) | 2003-02-07 | 2004-08-19 | Diagnocure Inc. | Method to detect prostate cancer in a sample |
EP1742966B1 (en) | 2004-04-22 | 2013-11-27 | Agensys, Inc. | Antibodies and molecules derived therefrom that bind to steap-1 proteins |
CA2491067A1 (en) | 2004-12-24 | 2006-06-24 | Stichting Katholieke Universiteit | Mrna rations in urinary sediments and/or urine as a prognostic marker for prostate cancer |
WO2006134917A1 (ja) * | 2005-06-14 | 2006-12-21 | Dnavec Corporation | 抗体の作製方法 |
WO2007035676A2 (en) | 2005-09-19 | 2007-03-29 | Veridex., Llc | Methods and materials for identifying the origin of a carcinoma of unknown primary origin |
US7622573B2 (en) * | 2006-01-17 | 2009-11-24 | Biolex, Inc. | Expression control elements from the lemnaceae family |
US7820174B2 (en) | 2006-02-24 | 2010-10-26 | The United States Of America As Represented By The Department Of Health And Human Services | T cell receptors and related materials and methods of use |
WO2007100568A2 (en) * | 2006-02-24 | 2007-09-07 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | T cell receptors and related materials and methods of use |
WO2008052187A2 (en) | 2006-10-27 | 2008-05-02 | Genentech. Inc. | Antibodies and immunoconjugates and uses therefor |
GB201513921D0 (en) * | 2015-08-05 | 2015-09-23 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers |
CA3055132A1 (en) | 2017-04-03 | 2018-10-11 | F. Hoffmann-La Roche Ag | Antibodies binding to steap-1 |
EP4584297A1 (en) * | 2022-09-11 | 2025-07-16 | Yeda Research and Development Co. Ltd | Anti-klk4 antibodies and uses thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU727823B2 (en) * | 1997-02-19 | 2000-12-21 | Jcam Agri. Co., Ltd. | Granular fertilizer coated with degradable film and method for producing the same |
US20030185830A1 (en) * | 1997-02-25 | 2003-10-02 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
IL131539A0 (en) * | 1997-02-25 | 2001-01-28 | Corixa Corp | Compounds for immunodiagnosis of prostate cancer and methods for their use |
IL140845A0 (en) * | 1998-07-14 | 2002-02-10 | Corixa Corp | Compositions for therapy and diagnosis of prostate cancer |
WO2001025272A2 (en) * | 1999-10-04 | 2001-04-12 | Corixa Corporation | Compositions and methods for therapy and diagnosis of prostate cancer |
CA2391369A1 (en) * | 1999-11-12 | 2001-05-17 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of prostate cancer |
HUP0203968A3 (en) * | 2000-01-14 | 2004-09-28 | Corixa Corp Seattle | Compositions and methods for the therapy and diagnosis of prostate cancer |
JP2005504513A (ja) * | 2001-05-09 | 2005-02-17 | コリクサ コーポレイション | 前立腺癌の治療及び診断のための組成物及び方法 |
-
2001
- 2001-03-27 EP EP01922786A patent/EP1311673A2/en not_active Withdrawn
- 2001-03-27 CA CA002403909A patent/CA2403909A1/en not_active Abandoned
- 2001-03-27 WO PCT/US2001/009919 patent/WO2001073032A2/en active Search and Examination
- 2001-03-27 JP JP2001570749A patent/JP2004504808A/ja active Pending
- 2001-03-27 AU AU2001249549A patent/AU2001249549A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001073032A2 (en) | 2001-10-04 |
JP2004504808A (ja) | 2004-02-19 |
EP1311673A2 (en) | 2003-05-21 |
AU2001249549A1 (en) | 2001-10-08 |
WO2001073032A3 (en) | 2003-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6800746B2 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US7939646B2 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US7033827B2 (en) | Prostate-specific polynucleotide compositions | |
CA2403909A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
EP1988097A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
CA2397741A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US6943236B2 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US7074898B2 (en) | Compositions and methods for therapy and diagnosis of prostate cancer | |
JP2004537252A (ja) | 前立腺癌の治療及び診断のための組成物及び方法 | |
US20020192763A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US6620922B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US6630305B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US6759515B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US6818751B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US20020193296A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US20020081680A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US20060269532A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US7048931B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US6894146B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US20020051977A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
US7517952B1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
JP2008271978A (ja) | 前立腺癌の治療及び診断のための組成物及び方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |